Early BioNTech mRNA breast cancer trial delivers surprise in longtime disease control
Triple-negative breast cancer is regarded as one of the most aggressive forms of the disease. Because tumour cells…
Here Are 2 With Even More Upside Ahead
On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to…